Journal of Cancer

Papers
(The H4-Index of Journal of Cancer is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
A snapshot of the PD-1/PD-L1 pathway113
Current Progress in CAR-T Cell Therapy for Hematological Malignancies105
An update in clinical utilization of photodynamic therapy for lung cancer65
Artemisinin Derivatives Inhibit Non-small Cell Lung Cancer Cells Through Induction of ROS-dependent Apoptosis/Ferroptosis60
The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma53
Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy51
Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications48
Regulation and biological functions of the CX3CL1-CX3CR1 axis and its relevance in solid cancer: A mini-review47
Akkermansia muciniphila administration exacerbated the development of colitis-associated colorectal cancer in mice44
Current Ovarian Cancer Maintenance Strategies and Promising New Developments36
GDF15/GFRAL Pathway as a Metabolic Signature for Cachexia in Patients with Cancer35
Consumption of sugar-sweetened beverages and fruit juice and human cancer: a systematic review and dose-response meta-analysis of observational studies32
FUT8 and Protein Core Fucosylation in Tumours: From Diagnosis to Treatment31
Six Novel Biomarkers for Diagnosis and Prognosis of Esophageal squamous cell carcinoma: validated by scRNA-seq and qPCR30
The Essential Factors of Establishing Patient-derived Tumor Model30
N6-methyladenosine RNA methylation regulators contribute to the progression of prostate cancer30
Cold atmospheric plasma selectively induces G0/G1 cell cycle arrest and apoptosis in AR-independent prostate cancer cells30
LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma29
FIN56, a novel ferroptosis inducer, triggers lysosomal membrane permeabilization in a TFEB-dependent manner in glioblastoma29
Construction of a Glycolysis-related long noncoding RNA signature for predicting survival in endometrial cancer29
Clinical diagnostic values of transfer RNA-derived fragment tRF-19-3L7L73JD and its effects on the growth of gastric cancer cells28
Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway28
Shikonin Inhibits Tumor Growth of ESCC by suppressing PKM2 mediated Aerobic Glycolysis and STAT3 Phosphorylation28
CAR-T cells for Colorectal Cancer: Target-selection and strategies for improved activity and safety28
LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinoma27
LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis27
Immune checkpoint inhibitor (ICI) combination therapy compared to monotherapy in advanced solid cancer: A systematic review26
Updates of Pathogenesis, Diagnostic and Therapeutic Perspectives for Ovarian Clear Cell Carcinoma26
LncRNA AC099850.3 promotes hepatocellular carcinoma proliferation and invasion through PRR11/PI3K/AKT axis and is associated with patients prognosis26
0.040248870849609